1. Home
  2. EE vs EVO Comparison

EE vs EVO Comparison

Compare EE & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Excelerate Energy Inc.

EE

Excelerate Energy Inc.

HOLD

Current Price

$33.23

Market Cap

1.2B

Sector

Utilities

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.11

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EE
EVO
Founded
2003
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
934.1M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
EE
EVO
Price
$33.23
$3.11
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$39.20
$7.00
AVG Volume (30 Days)
356.5K
111.3K
Earning Date
05-06-2026
04-08-2026
Dividend Yield
0.95%
N/A
EPS Growth
0.79
N/A
EPS
1.28
N/A
Revenue
$1,228,263,000.00
N/A
Revenue This Year
$23.59
$1.37
Revenue Next Year
$24.37
$10.05
P/E Ratio
$26.40
N/A
Revenue Growth
44.26
N/A
52 Week Low
$21.29
$2.31
52 Week High
$43.18
$4.80

Technical Indicators

Market Signals
Indicator
EE
EVO
Relative Strength Index (RSI) 43.82 58.88
Support Level $32.35 $2.87
Resistance Level $35.73 $3.78
Average True Range (ATR) 1.34 0.11
MACD 0.06 0.04
Stochastic Oscillator 29.29 66.95

Price Performance

Historical Comparison
EE
EVO

About EE Excelerate Energy Inc.

Excelerate Energy Inc offers LNG solutions, providing integrated services along the LNG value chain. It offers a full range of regasification services, from FSRUs to infrastructure development, to LNG and natural gas supply. Its business spans the globe, with a regional presence in 11 countries and an operational presence in Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: